Special Diabetes Program: Funding Opportunities
Below are current funding opportunities supported by the Special Diabetes Program. For other NIH funding opportunities, please see the NIH Guide for Grants and Contracts.
View archived research funding opportunities.
| Posted Date | Title | Open Date (Earliest Submission Date) | Application Due Date | Full Announcement |
|---|---|---|---|---|
| 1/4/2022 | Elucidating the Heterogeneity of Impaired Awareness of Hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed) | March 1, 2022 | March 31, 2022 | RFA-DK-21-036 |
| 1/4/2022 | Elucidating the Heterogeneity of Impaired Awareness of Hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required) | March 1, 2022 | March 31, 2022 | RFA-DK-21-020 |
| 12/3/2021 | New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) | May 1, 2022 | June 1, 2022 and March 20, 2023 | RFA-DK-21-030 |
| 8/12/2021 | High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01- Clinical Trial Not Allowed) | February 3, 2022 | March 3, 2022 | RFA-DK-21-017 |
| 7/28/2021 | Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) | February 3, 2022 | March 3, 2022 | RFA-DK-21-018 |
| 6/25/2021 | Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) | January 17, 2022 | February 17, 2022 and October 7, 2022 | RFA-DK-21-021 |
| 5/19/2021 | Support for Small Business Innovation Research (SBIR) Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) | February 9, 2022 | March 9, 2022 and October 7, 2022 | RFA-DK-21-012 |
| 5/6/2021 | Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) | February 9, 2022 | March 9 and October 7, 2022 | RFA-DK-21-011 |
| 3/17/2021 | The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) | May 22, 2021 | June 22, 2021 and March 9, 2022 | RFA-DK-21-004 |
| 1/3/2014 | Diabetic Complications Consortium Preclinical Testing Program | Ongoing | Not Applicable | DCC-PTP Website |